Literature DB >> 1934683

Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies.

L A Kalashnikova1, E L Nasonov, V V Borisenko, V B Usman, L Z Prudnikova, V U Kovaljov, A F Kushekbaeva.   

Abstract

Forty-one patients (31 women, 10 men) aged 15-56 (mean age, 38) with Sneddon's syndrome characterised by cerebrovascular disease and widespread livedo reticularis in the absence of typical lupus features were studied. 16 patients (39%) had clinical and/or electrocardiographic signs of ischemic heart disease, with 2 of them having survived myocardial infarction. Cardiac murmurs (usually mitral systolic) were heard in 15 patients (37%). Echocardiography revealed mitral valve thickening in 13 of 32 tested patients (41%). Anticardiolipin antibodies were found in 22 patients (54%) and lupus anticoagulant in 25 of 38 tested patients (66%). In 6 patients (15%) neither anticardiolipin antibodies nor lupus anticoagulant were observed. Anticardiolipin antibodies were more often present in patients with ischemic heart disease (12 of 16), than in those without (10 of 25) (p less than 0.05). Mitral valve thickening was revealed more often in patients with antiphospholipid antibodies (12 of 26 patients) than in those without (1 of 6); however, a statistically significant difference was not observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934683

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

Review 1.  The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.

Authors:  Markus Kraemer; Dieter Linden; Peter Berlit
Journal:  J Neurol       Date:  2005-08-26       Impact factor: 4.849

2.  A rarely seen syndrome in rehabilitation of hemiplegia: antiphospholipid antibody-negative Sneddon's syndrome.

Authors:  Ayla Akbal; Aydan Kurtaran; Barin Selçuk; Murat Ersöz; Müfit Akyüz
Journal:  Rheumatol Int       Date:  2009-08-21       Impact factor: 2.631

Review 3.  Anti-beta 2-glycoprotein I antibodies and thrombosis.

Authors:  J P Viard; Z Amoura; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  STEMI of the anterior wall associated with Sneddon's syndrome.

Authors:  S Scheuermann; C Schlundt
Journal:  Herz       Date:  2013-05-19       Impact factor: 1.443

Review 5.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

Review 6.  Sneddon's syndrome: a comprehensive review of the literature.

Authors:  Shengjun Wu; Ziqi Xu; Hui Liang
Journal:  Orphanet J Rare Dis       Date:  2014-12-31       Impact factor: 4.123

7.  Concomitant myocardial injury and valvular disease in Sneddon syndrome: a case report.

Authors:  Soukaina Scadi; Olivier Huttin; Christine Selton Suty; Denis Wahl
Journal:  Eur Heart J Case Rep       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.